Michel Sadelain is a genetic engineer and cell therapist at Memorial Sloan Kettering Cancer Center (MSKCC) in New York, where he holds the Steve and Barbara Friedman Chair. He is the founding director of the Center for Cell Engineering and a pioneer in T cell engineering and chimeric antigen receptor (CAR) therapy.
Agnes Lehuen is director of the Team “Immunology of diabetes” at Cochin Institute and University Paris City, France. She is cofounder of the Laboratory of Excellence INFLAMEX.
INEM is proud to announce The Celebration of the European Research Council Funding in Life Sciences: From Fundamental Discoveries to Innovative Life-Saving Therapies Symposium, an event co-organised with Association of ERC Grantees, Académine Nationale de Médecine de France and the Ministry of Higher Education and Research, set to showcase the pivotal role of European Research Council (ERC) funding in advancing life sciences research and innovation.
Highlights of the symposium
L'INEM se félicite de la sélection de Matthieu Mahévas parmi les lauréats de l’appel à projets « Chaires d'Excellence en Biologie-Santé » dans le cadre de l'initiative France 2030.
Le dispositif Chaire d’excellence en Biologie-Santé, un programme ambitieux de l'Agence Nationale de la Recherche, a pour objectif d’offrir à des chercheurs de premier plan et de toutes origines des financements conséquents pour mener en France de nouveaux projets d’envergure sur une durée de 5 ans.
Marcelle Machluf received her Ph.D. in Biotechnology Engineering from Ben-Gurion University (Israel), and then went on to complete a 5-year post-doctoral fellowship at the Harvard Medical School under the supervision of distinguished scholars Robert Langer and Anthony Atalla. During these years, she gained extensive hands-on experience with biomaterials and the development of biomedical platforms.
